Budikayanti Astri, Larasari Andira, Malik Khamelia, Syeban Zakiah, Indrawati Luh Ari, Octaviana Fitri
Department of Neurology, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Department of Psychiatry, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Neurol Res Int. 2019 Jun 2;2019:5902610. doi: 10.1155/2019/5902610. eCollection 2019.
Generalized anxiety disorder (GAD) is one of the most common types of anxiety disorder in epilepsy population, comprising 21.9%, that would further impair patients' quality of life. Generalized Anxiety Disorder-7 (GAD-7) is the only screening tool for GAD that has been validated in patients with epilepsy (PWE). It is a self-reporting instrument that can be completed in less than three minutes; hence, its usage is appropriate in primary healthcare and neurology outpatient clinic. This study aimed to obtain a valid and reliable Indonesian version of GAD-7, assess its accuracy, and finally evaluate the prevalence of GAD in Indonesian PWE along with its contributing factors.
A cross-sectional study was conducted in Cipto Mangunkusumo General Hospital, Jakarta. The GAD-7 was translated and adapted using World Health Organization (WHO) steps. Validity, reliability, test-retest reliability, and diagnostic accuracy were evaluated. Then, epilepsy outpatients were screened for GAD using the Indonesian version of GAD-7.
Internal validity and reliability for Indonesian version of GAD-7 were satisfactory with validity coefficient of 0.648 to 0.800 (p<0.01) and Cronbach's alpha value of 0.867. The best cutoff value to detect GAD in Indonesian PWE was >6 with the sensitivity, specificity, negative predictive value, and positive predictive value of 100%, 84.4%, 100%, and 55.8%, respectively. ROC analysis showed the area under the curve of 0.98 (95% CI: 0.96-0.99). The total subjects screened with the validated Indonesian version of GAD-7 were 146, and 49% were screened as having GAD. Sociodemographic and clinical characteristics had no statistically significant association with the presence of GAD.
The Indonesian version of GAD-7 was a valuable screening tool to detect GAD in PWE. GAD was screened in a quite high proportion of PWE. Sociodemographic and clinical characteristics were not proven to play role in its development.
广泛性焦虑障碍(GAD)是癫痫患者中最常见的焦虑障碍类型之一,占比21.9%,这会进一步损害患者的生活质量。广泛性焦虑障碍量表-7(GAD-7)是唯一在癫痫患者(PWE)中得到验证的GAD筛查工具。它是一种自我报告工具,可在三分钟内完成;因此,它适用于初级医疗保健和神经内科门诊。本研究旨在获得一个有效且可靠的印尼语版GAD-7,评估其准确性,并最终评估印尼PWE中GAD的患病率及其影响因素。
在雅加达的西托·曼古库苏莫综合医院进行了一项横断面研究。GAD-7采用世界卫生组织(WHO)的步骤进行翻译和改编。评估了效度、信度、重测信度和诊断准确性。然后,使用印尼语版GAD-7对癫痫门诊患者进行GAD筛查。
印尼语版GAD-7的内部效度和信度令人满意,效度系数为0.648至0.800(p<0.01),克朗巴哈系数值为0.867。在印尼PWE中检测GAD的最佳临界值>6,敏感性、特异性、阴性预测值和阳性预测值分别为100%、84.4%、100%和55.8%。ROC分析显示曲线下面积为0.98(95%CI:0.96-0.99)。使用经过验证的印尼语版GAD-7筛查的总受试者为146人,其中49%被筛查为患有GAD。社会人口统计学和临床特征与GAD的存在无统计学显著关联。
印尼语版GAD-7是检测PWE中GAD的有价值的筛查工具。相当高比例的PWE被筛查出患有GAD。社会人口统计学和临床特征未被证明在其发病中起作用。